SAFETY AND EFFICACY OF TOCILIZUMAB (ANTI-IL6R, TCZ) THERAPY IN THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION (CABMR) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS.

被引：0
|
作者：
Puliyanda, D. [1 ]
Kim, I. [2 ]
Choi, J. [2 ]
Haas, M. [2 ]
Zhang, X. [2 ]
Vo, A. [2 ]
Pizzo, H. [1 ]
Jordan, S. [2 ]
机构：
[1] Cedars Sinai Med Ctr, Pediat Nephrol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
PEDIATRIC TRANSPLANTATION | 2017年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
201.5
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [31] Anti-Interleukin 6 Therapeutics for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients
    Sharma, Rajeev
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (08) : 709 - 716
  • [32] Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody Tocilizumab
    Sivapalaratnam, Suthesh
    Linpower, Lisa
    Sirigireddy, Bala
    Agapidou, Alexandra
    Jain, Susan
    Win, Nay
    Tsitsikas, Dimitris A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (06) : E212 - E214
  • [33] Monitoring Inflammatory Cytokine Levels in Kidney Transplant Patients (KTx Pts) with Chronic Antibody Mediated Rejection (cABMR) Treated with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody).
    Ge, S.
    Petrosyan, A.
    Chu, M.
    Ammerman, N.
    Vo, A.
    Jordan, S. C.
    Zhang, X.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 661 - 661
  • [34] Efficacy of treatment with the IL-6R inhibitor tocilizumab (TCZ) in patients with active RA despite MTX therapy: The option study
    Beaulieu, Andre D.
    Rubbert-Roth, A.
    Woodworth, T.
    Alecock, E.
    Alten, R.
    Laughton, J.
    Eves, D.
    Smolen, J.
    RHEUMATOLOGY, 2008, 47 : II15 - II16
  • [35] ISOLATED ANGIOTENSIN II RECEPTOR TYPE I ANTIBODIES (AT1R) ARE NOT ASSOCIATED WITH ACTIVE ANTIBODY MEDIATED REJECTION (ABMR) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS.
    Choi, J.
    Haas, M.
    Zhang, X.
    Aubert, O.
    Pizzo, H.
    Kamil, E.
    Jordan, S.
    Puliyanda, D.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 45 - 45
  • [36] Effectiveness of Rituximab and Intravenous Immunoglobulin Therapy in Renal Transplant Recipients with Chronic Active Antibody-Mediated Rejection
    Hong, Y. A.
    Kim, H. G.
    Choi, S. R.
    Sun, I. O.
    Park, H. S.
    Chung, B. H.
    Choi, B. S.
    Park, C. W.
    Kim, Y. S.
    Yang, C. W.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (01) : 182 - 184
  • [37] The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients
    An, Gun Hee
    Yun, Jintak
    Hong, Yu Ah
    Khvan, Marina
    Chung, Byung Ha
    Choi, Bum Soon
    Park, Cheol Whee
    Choi, Yeong Jin
    Kim, Yong-Soo
    Yang, Chul Woo
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014 : 828732
  • [38] Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience
    Yilmaz, Vural Taner
    Dandin, Ozgur
    Kisaoglu, Abdullah
    Avanaz, Ali
    Kamaci, Davut
    Toru, Havva Serap
    Demiryilmaz, Ismail
    Koksoy, Sadi
    Aydinli, Bulent
    Kocak, Huseyin
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (07) : 1809 - 1815
  • [39] Outcome of Renal Transplant Recipients With Chronic Antibody Mediated Rejection - The Role of Intravenous Immunoglobulin and Plasmapheresis Treatment.
    Ma, M.
    Lam, M.
    Choy, C.
    Chan, T.
    TRANSPLANTATION, 2014, 98 : 511 - 511
  • [40] Outcome of Renal Transplant Recipients With Chronic Antibody Mediated Rejection - The Role of Intravenous Immunoglobulin and Plasmapheresis Treatment.
    Ma, M.
    Lam, M.
    Choy, C.
    Chan, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 511 - 511
12345